Approval · Notice of Compliance 35099 · 2025
KAVIGALE: Notice of Compliance 35099
Issued March 21, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35099
- Date
- March 21, 2025
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KAVIGALE | 02556332 | Approved |
Medicinal ingredients
- SIPAVIBART 150 MG per ML